Phase II open-label study of volociximab in combination with DTIC in patients with metastatic melanoma not previously treated with chemo

Trial Profile

Phase II open-label study of volociximab in combination with DTIC in patients with metastatic melanoma not previously treated with chemo

Completed
Phase of Trial: Phase II

Latest Information Update: 10 Sep 2007

At a glance

  • Drugs Dacarbazine; Volociximab
  • Indications Malignant melanoma
  • Focus Therapeutic Use
  • Most Recent Events

    • 10 Sep 2007 Status change from in progress to completed
    • 19 Sep 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top